MYOM2 and prostate carcinoma: Our assessment using the cBioportal online database revealed that decreased MYOM2 expression is associated with significantly worse progression free survival in prostate cancer patients compared to those with high MYOM2 expression, suggesting that MYOM2 may be another potential marker for identifying aggressive prostate cancer.